Literature DB >> 9440875

Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10.

L Shen1, A M Shah, B Dahlbäck, G L Nelsestuen.   

Abstract

Bovine and human protein C show high homology in the amino acids of their GLA domains (amino-terminal 44 residues), despite the about 10-fold higher membrane affinity of the human protein. A proposed membrane contact site and mechanism suggested that this difference was largely due to the presence of proline at position 10 of bovine protein C versus histidine at position 10 of human protein C [McDonald, J.F., Shah, A.M., Schwalbe, R.A., Kisiel, W., Dahlback, B., and Nelsestuen, G.L. (1997) Biochemistry, 36, 5120-5127]. This study examined the impact of replacing proline-10 in bovine protein C with histidine, and the reverse change in human protein C. In both cases, the protein containing proline-10 showed lower membrane affinity, about 10-fold lower for bovine protein C and 5-fold lower for human protein C. As expected, activated human protein C (hAPC) containing proline at position 10 showed 2.4-3.5-fold lower activity than wild type hAPC, depending on the assay used. Most interesting was that bovine APC containing histidine-10 displayed up to 15-fold higher activity than wild type bAPC. This demonstrated the ability to improve both membrane contact and activity by mutation. This general strategy should be applicable to other vitamin K-dependent proteins, providing opportunities to study function as well as to produce proteins that may find use as promoters and inhibitors of blood coagulation in pathological states.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440875     DOI: 10.1021/bi971730v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.

Authors:  Cecilia Oslakovic; Eva Norstrøm; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2010-05       Impact factor: 14.808

3.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

Review 4.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

5.  Computational study of coagulation factor VIIa's affinity for phospholipid membranes.

Authors:  Olivier Taboureau; Ole Hvilsted Olsen
Journal:  Eur Biophys J       Date:  2006-11-28       Impact factor: 2.095

6.  Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Authors:  Ruzica Livaja Koshiar; Sofia Somajo; Eva Norström; Björn Dahlbäck
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.